G
Gerald L. Andriole
Researcher at Washington University in St. Louis
Publications - 61
Citations - 21086
Gerald L. Andriole is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 31, co-authored 47 publications receiving 19823 citations.
Papers
More filters
Journal ArticleDOI
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole,E. David Crawford,Robert L. Grubb,Saundra S. Buys,David Chia,Timothy R. Church,Mona N. Fouad,Edward P. Gelmann,Paul A. Kvale,Douglas J. Reding,Joel L. Weissfeld,Lance A. Yokochi,Jonathan D. Clapp,Joshua M. Rathmell,Thomas L. Riley,Richard B. Hayes,Barnett S. Kramer,Anthony B. Miller,Paul F. Pinsky,Philip C. Prorok,John K. Gohagan,Christine D. Berg +21 more
TL;DR: After 7 to 10 years of follow-up, the rate of death from prostate cancer was very low and did not differ significantly between the two study groups.
Journal ArticleDOI
Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.
William J. Catalona,Deborah S. Smith,Timothy L. Ratliff,Kathy M. Dodds,Douglas E. Coplen,Jerry J.J. Yuan,John A. Petros,Gerald L. Andriole +7 more
TL;DR: The combination of measurement of the serum PSA concentration and rectal examination, with ultrasonography performed in patients with abnormal findings, provides a better method of detecting prostate cancer thanrectal examination alone.
Journal ArticleDOI
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
John D. McConnell,Claus G. Roehrborn,Oliver Bautista,Gerald L. Andriole,Christopher M. Dixon,John W. Kusek,Herbert Lepor,Kevin T. McVary,Leroy M. Nyberg,Harry Clarke,E. David Crawford,Ananias C. Diokno,John P. Foley,Harris E. Foster,Stephen C. Jacobs,Steven A. Kaplan,Karl J. Kreder,Michael M. Lieber,M. Scott Lucia,Gary J. Miller,Mani Menon,Douglas F. Milam,Joe W. Ramsdell,Noah S. Schenkman,Kevin M. Slawin,Joseph A. Smith +25 more
TL;DR: Long-term combination therapy with doxazosin and finasteride was safe and reduced the risk of overall clinical progression of benign prostatic hyperplasia significantly more than did treatment with either drug alone.
Journal ArticleDOI
Radical prostatectomy versus observation for localized prostate cancer.
Timothy J Wilt,Michael K. Brawer,Karen M. Jones,Michael J. Barry,William J. Aronson,Steven Fox,Jeffrey R. Gingrich,John T. Wei,Patricia Gilhooly,B. Mayer Grob,Imad Nsouli,Padmini Iyer,Ruben Cartagena,Glenn Snider,Claus G. Roehrborn,Roohollah Sharifi,William Blank,Parikshit Pandya,Gerald L. Andriole,Daniel J. Culkin,Thomas M. Wheeler +20 more
TL;DR: Among men with localized prostate cancer detected during the early era of PSA testing, radical prostatectomy did not significantly reduce all-cause or prostate-cancer mortality, as compared with observation, through at least 12 years of follow-up.
Journal ArticleDOI
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
Meredith Yeager,Nick Orr,Richard B. Hayes,Kevin B. Jacobs,Peter Kraft,Sholom Wacholder,Mark J Minichiello,Paul Fearnhead,Kai Yu,Nilanjan Chatterjee,Zhaoming Wang,Zhaoming Wang,Robert W Welch,Robert W Welch,Brian Staats,Brian Staats,Eugenia E. Calle,Heather Spencer Feigelson,Michael J. Thun,Carmen Rodriguez,Demetrius Albanes,Jarmo Virtamo,Stephanie J. Weinstein,Fredrick R. Schumacher,Edward Giovannucci,Walter C. Willett,Geraldine Cancel-Tassin,Olivier Cussenot,Antoine Valeri,Gerald L. Andriole,Edward P. Gelmann,Margaret A. Tucker,Daniela S. Gerhard,Joseph F. Fraumeni,Robert N. Hoover,David J. Hunter,David J. Hunter,Stephen J. Chanock,Gilles Thomas +38 more
TL;DR: Observations indicate the presence of at least two independent loci within 8q24 that contribute to prostate cancer in men of European ancestry, and it is estimated that the population attributable risk of the new locus, marked by rs6983267, is higher than the locus marked byrs1447295.